Studies show that structured follow-up careincluding nutritionist support, regular activity tracking, and periodic check-insimproves outcomes after discontinuation
J Diabetes Res 2015:e806979 Nielsen LL (2005) Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes
Factors that may influence mental clarity during treatment: Rapid weight loss leading to temporary metabolic adjustment Changes in dietary intake affecting blood glucose levels Changes in sleep patterns associated with weight loss Concurrent medications or underlying health conditions It's worth noting that Saxenda alone rarely causes hypoglycaemia in people without diabetes, though the risk increases if combined with insulin or sulfonylureas in those with diabetes
For AUC 06h,SNAC,day10 and C max,SNAC,day10 , there was no statistically significant interaction between the effects of water volume and post-dose fasting ( p = 0.609 and p = 0.732, respectively) and no statistically significant change with water volume ( p = 0.396 and p = 0.848, respectively)
This dual weight-reducing effect can be particularly beneficial for patients with type 2 diabetes and obesity, addressing two interconnected metabolic abnormalities simultaneously
